Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The designation "Not a discrete molecular target" is used in pharmacology to identify therapeutic agents that do not interact with a specific biological macromolecule, such as a receptor or enzyme, to produce a clinical effect. Instead, these agents work through physicochemical mechanisms that alter the local environment of a tissue or involve direct chemical reactions (Gaulton et al., 2012). For example, antacids like calcium carbonate function by directly neutralizing gastric hydrochloric acid, thereby increasing the pH of the stomach contents to relieve heartburn (Salisbury & Terrell, 2023). Osmotic laxatives, such as polyethylene glycol or magnesium salts, create an osmotic gradient that retains water within the intestinal lumen to facilitate bowel movements (Bashir & Sizar, 2023). Other substances, like simethicone, act as surfactants to reduce the surface tension of gas bubbles, while phosphate binders like sevelamer physically sequester ions in the gut. Because these treatments lack a specific protein binding site, they generally do not exhibit stereoselectivity and often require higher dosages than targeted molecular therapies. This category is essential for classifying drugs that provide significant therapeutic utility through non-biological, bulk physical or chemical interactions.
Drugs associated with this classification exert their effects through physicochemical processes such as the chemical neutralization of acids, the creation of osmotic gradients to move water, or the physical binding of ions in the gastrointestinal tract.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Not a discrete molecular target.